Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-08
2005-02-08
McKenzie, Thomas C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S235800, C514S236500, C514S236800, C514S241000, C514S245000, C514S252140, C514S269000, C514S272000, C514S273000, C514S274000, C514S342000, C514S346000, C514S407000, C514S459000, C544S123000, C544S124000, C544S140000, C544S211000, C544S212000, C544S219000, C544S295000, C544S312000, C544S319000, C544S321000, C546S270700, C546S279100, C546S291000, C548S371700, C549S292000, C549S419000
Reexamination Certificate
active
06852717
ABSTRACT:
Disclosed are compounds useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are processes of making such compounds.
REFERENCES:
patent: 4435567 (1984-03-01), Lugosi et al.
patent: 6211373 (2001-04-01), Widdowson et al.
patent: 6262113 (2001-07-01), Widdowson et al.
patent: 6297381 (2001-10-01), Cirillo et al.
patent: 6319921 (2001-11-01), Cirillo et al.
patent: 6329415 (2001-12-01), Cirillo et al.
patent: 6333325 (2001-12-01), Cirillo et al.
patent: 0 395 144 (1990-10-01), None
patent: 0 418 071 (1991-03-01), None
patent: 1005237 (1965-09-01), None
patent: WO 9324458 (1993-12-01), None
patent: WO 9418170 (1994-08-01), None
patent: WO 9716442 (1997-05-01), None
patent: WO 9852558 (1998-11-01), None
patent: WO 9852559 (1998-11-01), None
patent: WO 9932106 (1999-07-01), None
patent: WO 9932110 (1999-07-01), None
patent: WO 9932111 (1999-07-01), None
patent: WO 9932455 (1999-07-01), None
patent: WO 9932463 (1999-07-01), None
patent: WO 0043384 (2000-07-01), None
patent: WO 0055139 (2000-09-01), None
patent: WO 0136402 (2001-05-01), None
Chantry, D., Emerging Drugs, 1999, Chapter 1, pp. 5-13.*
Raine, C.S., et al; Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque. Rev Nueroi (Paris) 1998: 154:8-9; 577-585.
MA, J.J., et al; Genetic Contribution of the Tumor Necrosis Factor Region in Guillain-Barre Syndrome , Annals of Neurology vol. 44, No. 5, Nov. 1998, pp. 815-818.
Chodorowska, G., Plasma concentrans of IFN-y and TNF-a in psoriatic patients before and after local treatment with dithranol ointment. Journal of the European Academy of Dermatology and Venerology 10 (1998) pp. 147-151.
Nagler, A., et al; Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation. Cytokines, Cellular & Molecular Therapy (1998) vol. 4, pp. 161-167.
Robak, E., et al; Association of Interferon y, Tumor Necrosis Factor a and Interleukin 6 Serum Levels with Systemic Lupus Erythematosus Activity; Archivum Immunologiae et Therapiae Experimentalis, 1998 46, 375-380.
Tashiro, H., et al; Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty, Coronary Artery Disease, 2001, vol. 12, No. 2, pp 107-113.
Storz, P., et al; TNF inhibits insulin induced STAT5 activation in differentiated mouse muscle cells pmi28. FEBS Letters 440 (1998) 41-45.
Brown, G., et al; Lymphold Hyperplasia, CD45RBhigh to CD45RBlow T-cell imbalance, and suppression of Type 1 diabetes mellitus result from TNF blockade in NOD NOD-scid adoptive T cell transfer, Diabetologia (1998) 41; 1502-1510.
Bjugstad, K.B., et al; Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia, Brain Research 795 (1998) 349-357.
Chou, R.C., et al; Adrenergic regulation of macrophage-derived tumor necrosis factor-a generation during a chronic polyarthritis pain model, Journal of Neuroimmunology 82 (1998) 140-148.
Mueller, G., et al; Is Cytokine Expression Responsible for Differences between Allergens and Irritants? American Journal of Contact Dermatitis, vol. 7, No. 3, Sep. 1996 pp 177-184.
Mitsui, Y., et al; The expression of proinflammatory cytokine mRNA in the sciatic-tibal nerve of ischemia-reperfusion injury. Brain Research 844 (1999) 192-195.
Lemay, S., et al; Prominent and Sustained Up regulation of gp130-Signalling Cytokines and of the Chemokine MIP-2 in Murine Renal Ischemia-Reperfusion Injury. Transplantation vol. 69. No. 5 pp. 959-963.
Boerjesson, A., et al; TNF-a stimulates alveolar liquid clearance during intestinal ischemia-reperfusion in rats. American Journal Physiol. Lung-Cel Mol. Physiol., 278—L3-L12, 2000.
Kurokouchi, K.et al; TNF-a Increases Expression of IL-6 and ICAM-1 Genes Through Activation of NF-kb in Osteoblast-like ROS17/2.8 Cells; Journal of Bone and Mineral Research, vol. 15 No. 8, 1998 pp. 1290 1299.
Higham, M.A., et al; Tumour necrosis factor-a gene promoter polymorphism in chronic obstructive pulmonary disease; European Respiratory Jouranl 2000; 15; pp 281-284.
Takabatake, N., et al; The Relationship between Chronic Hypoxemia and Activation of the Tumor Necrosis Factor-a system in Patients with Chronic Obstructive Pulmonary Disease American Journal Of Respiratory Critical Care Medicine, vol. 161, pp 1179-1184, 2000.
Lee, T.H., Cytokine networks in the pathogenesis of bronchial asthma; implications for therapy Journal of the Royal College of Physicians of London, vol. 32, No. 1, Jan./Feb. 1998.
Lipton, J.M., et al; Peptide Modulation of Inflammamatory Processes within the Brain, Neuroimmunomodulation 1998, pp 178-183.
Li, D., et al; Kinetics of tumor necrosis factor a in plasma and the cardioprotective effect of a monoclonial antibody to tumor necrosis factor a in acute myocardial infarction, American Heart Journal, 1999, pp 1146-1152.
Yeh, F.L, et al; Changes in serum tumour necrosis factor-a in burned patients. Burns, vol. 23 Bi, 1, pp. 6-10, 1997.
Renzetti, L.M., et al; Ro 45-2081, a TNF receptor fusion protein, prevents inflammatory responses in the airways, Inflammation Research 46, Supplement 2, (1997), S143-S144.
Paris, M., et al; The Effect of Interleukinn-10 on Meningeal Inflammation in Experimental Bacterial Meningitis. Journal of Infectious Diseases 1997; 176:1239-1246.
Viscardi, R., et al; Inflammatory Cytokine MRNAs in Surgical Specimens of Necrotizing Enterocolitis and Normal Newborn Intestine. Pediatric Pathology of Laboratory Medicine 17:547-559, 1997.
Cirillo Pier Francesco
Goldberg Daniel R.
Hammach Abdelhakim
Moss Neil
Regan John Robinson
Boehringer Ingelheim Pharmaceuticals Inc.
Bottino Anthony P.
McKenzie Thomas C.
Raymond Robert P.
Witkowski Timothy X.
LandOfFree
Compounds useful as anti-inflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds useful as anti-inflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds useful as anti-inflammatory agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3461335